• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Taysha Gene Therapies Inc (NQ: TSHA )

    2.270 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1
    Open 2.270
    Bid (Size) 2.300 (4)
    Ask (Size) 2.380 (2)
    Prev. Close 2.270
    Today's Range 2.270 - 2.270
    52wk Range 0.6200 - 4.320
    Shares Outstanding 64,465,037
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Where Taysha Gene Therapies Stands With Analysts
    Via Benzinga
    Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today?
    Taysha Gene Therapies stock is down on Wednesday after the company announced a proposed public offering for TSHA shares. 
    Via InvestorPlace

    Performance

    YTD
    +32.75%
    +32.75%
    1 Month
    -7.91%
    -7.91%
    3 Month
    -1.30%
    -1.30%
    6 Month
    +54.42%
    +54.42%
    1 Year
    +250.58%
    +250.58%

    More News

    Read More
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    The Analyst Landscape: 16 Takes On Taysha Gene Therapies
    Via Benzinga
    Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views
    Via Benzinga
    11 Analysts Assess Taysha Gene Therapies: What You Need To Know
    Via Benzinga
    Evaluating Taysha Gene Therapies: Insights From 7 Financial Analysts
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    S&P 500 Edges Higher; America's Car-Mart Shares Tumble After Q4 Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Crude Oil Rises 1%; DermTech Shares Plummet
    Via Benzinga
    Exposures Fossil Fuels
    What's Going On With Taysha Gene Therapies Stock Tuesday?
    Via Benzinga
    TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease
    Via Benzinga
    Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Taysha Gene Therapies Shares Jump On Initial Data From First Pediatric Patient With Rare Neurodevelopmental Disorder
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.